What did @phaellotshabalala actually say?
Three weeks into tirzepatide (Mounjaro), @phaellotshabalala delivered a mostly sensible message: the drug is not a passive fix. "Manjaro is not a miracle jab," they said, and pushed back on the idea that you can "just chill and it will do the job." They flagged muscle loss as a real risk, called out the need for strength training and adequate protein, and disclosed a sponsorship from Nila Aesthetics. They also reported losing roughly 6 kilograms in under three weeks. Throughout, they reminded viewers they are not a medical professional.
That is more responsible framing than most GLP-1 content on TikTok. Still, several specific claims deserve scrutiny, and one reported outcome raises legitimate questions.
Does the science back this up?
The core argument, that calories in versus calories out still governs weight loss even on GLP-1 medications, is correct. Tirzepatide works partly by suppressing appetite, which mechanically reduces caloric intake. It does not override energy balance; it makes adherence to a deficit easier. The SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed mean weight loss of around 20% over 72 weeks, but participants were also counselled on diet and activity. The drug creates the conditions for a deficit, it does not replace one.
The muscle loss warning is also grounded in evidence. A 2024 analysis by Ida et al. in Diabetes Care found that roughly 25-39% of weight lost on GLP-1 receptor agonists can come from lean mass, depending on protein intake and resistance training. Prioritising both is not optional advice; it is a real clinical concern.
What did they get wrong (or right)?
Let's start with what they got right, because credit is due. Calling out muscle loss risk, pushing protein, and demanding strength training is genuinely good advice that most GLP-1 influencers skip entirely. The sponsorship disclosure is also legally required under ASA and FTC rules, and they included it.
Now, the number that deserves scrutiny: "I've lost just about 6 kilograms in under 3 weeks." That is approximately 13 pounds in 21 days. Physiologically plausible? Barely, and only if a significant portion is water and glycogen depletion, not fat tissue. One kilogram of fat requires roughly a 7,700 kcal deficit. Losing 6 kg of fat in three weeks would require a deficit of over 2,200 kcal per day, every day. That is not realistic. The creator does not distinguish between fat loss and total weight loss, which matters enormously when the stated goal is fat reduction. This is not a minor omission when the video is tagged with "weightlosstransformation."
Reporting raw scale numbers without context can mislead viewers into expecting similar results, or into under-eating to chase the number.
What should you actually know?
Tirzepatide is a dual GIP/GLP-1 receptor agonist, which makes it mechanistically different from semaglutide (Ozempic, Wegovy). The SURMOUNT programme consistently showed it outperforms semaglutide on weight outcomes, but that comparison comes from separate trials, not head-to-head data at equivalent doses. The point is: results vary, and three weeks of data from one person tells you almost nothing about what you will experience.
The muscle loss concern is real enough that some clinicians now co-prescribe resistance training protocols rather than suggesting them. A 2023 paper by Cava et al. in Obesity Reviews found that protein intakes of 1.2-1.6 g per kg of body weight per day helped preserve lean mass during caloric restriction. That aligns with what the creator recommended, even if they did not cite a number.
Finally: the creator is sourcing their medication through a sponsored aesthetics clinic. That is not inherently problematic, but anyone watching should confirm their provider conducts a proper medical assessment, monitors for pancreatitis, thyroid changes, and gastrointestinal side effects, and adjusts dosing under clinical supervision, not based on TikTok timelines.